Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Health Hope Pharma (HHP), headquartered in Hong Kong, is a clinical-stage oncology company focused on developing novel oral anti-cancer therapies. Leveraging its proprietary Orascovery platform and lead compound Encequidar, a potent P-glycoprotein inhibitor, HHP enables the effective oral delivery of chemotherapeutic agents like paclitaxel. By transforming IV therapies into oral options, HHP aims to improve patient convenience...
Health Hope Pharma (HHP), headquartered in Hong Kong, is a clinical-stage oncology company focused on developing novel oral anti-cancer therapies. Leveraging its proprietary Orascovery platform and lead compound Encequidar, a potent P-glycoprotein inhibitor, HHP enables the effective oral delivery of chemotherapeutic agents like paclitaxel. By transforming IV therapies into oral options, HHP aims to improve patient convenience, reduce toxicities, and advance more accessible, effective cancer treatments.

List your booth number for exhibitions, ask us